Image of Bioequivalence Study of Modified Release Formulation (MRF) of Loratadine and Pseudoephedrine Fixed Combination

LITERATURE

Bioequivalence Study of Modified Release Formulation (MRF) of Loratadine and Pseudoephedrine Fixed Combination


The present study was conducted to find out whether the bioavailability of PT Dexa Medica’s modified-release formulation (MRF) of pseudoephedrine and loratadine fixed combination (Rhinos®SR) was comparable to that produced by the reference’s company. The pharmacokinetic parameters assessed in this study were area under the serum concentration - time curve during one dosing interval (AUC0-12h), peak serum concentration of the drug (Cmax), trough serum concentration, i.e., concentration at the end of the dosing
interval (Cmin), average serum concentration, i.e., average serum concentration during one dosing interval (Cav), the fluctuation index (FI) and swing, at steady-state


Availability

Rhinos SR-004Available

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Specific Detail Info
-
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous